Skip to main content

Posts

Showing posts with the label atherogenic risk

Effect of Cymbopogon citratus Stapf (DC) on Type 2 Diabetes Mellitus-induced Dyslipidemia: Current Knowledge | Chapter 11 | Current Trends in Medicine and Medical Research Vol. 3

Introduction: Diabetic dyslipidemia (DD)  is  a collection  of  quantitative,  qualitative and  kinetic  lipid abnormalities associated with diabetes mellitus that together caused the lipid profile to become more atherogenic.  It  consists  of  elevated  serum  concentration  of  triglyceride-cholesterol  (TG-C),  a  high serum level of small dense low density lipoprotein-cholesterol (sd LDL-C), low level of high-density lipoprotein-cholesterol (HDL-C) and normal to slightly elevated level of total low density lipoprotein-cholesterol (LDL-C). Aims: Diabetic  dyslipidemia  is  a  recognized  risk  factor  for  coronary  heart  disease  (CHD). Plant medicinal  agents  such  as Cymbopogon  citratus (C.  citratus)  have  shown  potential  as alternative therapies for reducing cardiovascular ...